Practical and highly interactive breakout roundtables where attendees can crowdsource solutions and share opinions around pre-assigned topic areas.

• How should genetic testing be integrated into routine diagnosis and clinical trial enrollment?
• To what extent are clinical guidelines (e.g., KDIGO) keeping pace with advances in genetic testing, and what gaps still need to be addressed?
• How are regulators likely to evaluate genotype-defined patient populations and nmutation-specific therapies in rare kidney disease trials?

Moderator Feedback & Audience Debate

Moderators will be assigned to each roundtable to facilitate discussion and collate

the findings. Following the roundtable discussions, they will present back to the entire

delegation and open wider audience debate